SCHEMBL3963145

SCHEMBL3963145

CCCCCCC(=O)NCC1CCCCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.58
CNR2 P34972 4/20 0.52
CNR1 P21554 3/20 0.52
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
GBA1 P04062 1/20 0.49
NAAA Q02083 2/20 0.49
METAP2 P50579 1/20 0.48
TP53 P04637 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19957328 1.00 FAAH (0.58) FAAHCNR2CNR1HDAC3HDAC4
SCHEMBL19154742 0.98 FAAH (0.60) FAAHCNR2CNR1HDAC3HDAC4
SCHEMBL27405108 0.98 FAAH (0.60) FAAHCNR2CNR1HDAC3HDAC4
SCHEMBL13519 0.93 FAAH (0.57) FAAHCNR2CNR1HDAC3HDAC4
SCHEMBL30259898 0.91 FAAH (0.59) FAAHCNR2CNR1HDAC3HDAC4
SCHEMBL17335652 0.90 FAAH (0.69) FAAHCNR2CNR1GBA1
SCHEMBL5153025 0.89 FAAH (0.54) FAAHCNR2CNR1GBA1TP53
SCHEMBL10596582 0.89 FAAH (0.54) FAAHCNR2CNR1GBA1TP53
SCHEMBL22580775 0.88 FAAH (0.81) FAAHCNR1HPGDALOX12
SCHEMBL9202 0.86 EPHX1 (0.53) FAAHHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7488844-B2 Therapeutic agents ASTRAZENECA AB (SE) 2009-02-10 US disclosed
US-7256307-B2 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR) ASTRAZENECA AB (SE) 2007-08-14 US disclosed
EP-1458672-B1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR) ASTRAZENECA AB (SE) 2007-05-30 EP disclosed
US-20050282822-A1 Therapeutic agents ASTRAZENECA AB (SE) 2005-12-22 US disclosed
US-20050113362-A1 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) ASTRAZENECA AB R & D HEADQUARTERS - GLOBAL IINTELLECTUAL PROPERT (SE) 2005-05-26 US disclosed
EP-1458672-A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR) AstraZeneca AB (SE) 2004-09-22 EP disclosed
WO-2003051822-A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR) ASTRAZENECA AB (SE) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282822-A1 Therapeutic agents GPR119, LIPC, PNLIP FAAH 3177/4885CNR2 2251/4885CNR1 1313/4885
US-20050113362-A1 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) PPARA, PPARD, PPARG FAAH 627/4885CNR2 276/4885CNR1 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.